Table 3.
Risk factors of poor outcome (moderate/severe/profound developmental delay) compared to a good outcome (borderline/mild developmental delay and normal development) using univariate and multivariable logistic regression models (n = 326)
Univariate logistic regression | Multivariate logistic regression | |||
---|---|---|---|---|
OR (95% CI) | P-value | aOR (95% CI) | p-value | |
Age < 4 years | 4.18 (1.73–10.08) | < 0.001 | 2.12 (0.80–5.62) | 0.130 |
Fever | 1.15 (0.63–1.68) | 0.764 | ||
Convulsions | 1.93 (1.11–1.87) | 0.025 | 1.39 (0.73–2.63) | 0.317 |
HIV infected | 1.08 (0.20–5.75) | 1.000 | ||
Household TB contact | 0.85 (0.50–1.43) | 0.590 | ||
BCG scar or documentation | 1.22 (0.69–2.13) | 0.575 | ||
Weight faltering/loss | 1.01 (0.45–2.29) | 1.000 | ||
Decreased LOC | 5.28 (1.85–15.13) | < 0.001 | 4.68 (1.58–13.88) | 0.005 |
Brainstem dysfunction | 4.13 (2.38–7.15) | < 0.001 | 3.20 (1.70–6.00) | < 0.001 |
Motor function impaired | 4.52 (2.27–9.00) | < 0.001 | 1.72 (0.78–3.79) | 0.177 |
Advanced TBM stage (2b and 3) | 12.20 (1.65–90.50) | 0.001 | 1.99 (0.23–17.05) | 0.530 |
CSF leucocytes 10–500 cells/L | 0.75 (0.43–1.32) | 0.379 | ||
CSF lymphocytes > 50% | 1.95 (0.79–4.82) | 0.173 | ||
CSF protein > 1 g/L | 0.80 (0.443–1.48) | 0.515 | ||
CSF glucose < 2.2 mmol/L | 1.46 (0.75–2.83) | 0.337 | ||
CSF- Mtb Culture positive | 0.37 (0.14–0.96) | 0.038 | 0.37 (0.13–1.06) | 0.065 |
Radiological infarction | 4.02 (2.43–6.64) | < 0.001 | 3.47 (1.87–6.45) | < 0.001 |
Basal enhancement | 1.12 (0.53–2.36) | 0.853 | ||
Hydrocephalus | 2.36 (0.69–7.18) | 0.224 | ||
Tuberculoma(s) | 0.79 (0.35–1.79) | 0.694 |
OR odds ratio, CI confidence interval, aOR adjusted odds ratio, HIV human immunodeficiency virus, TB tuberculosis, BCG Bacille Calmette-Guerin, LOC level of consciousness, TBM tuberculous meningitis, CSF cerebrospinal fluid, Mtb Mycobacterium tuberculosis